| Pharmacogenomics knowledge for personalized medicine M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ... Clinical Pharmacology & Therapeutics 92 (4), 414-417, 2012 | 2103 | 2012 |
| Personal omics profiling reveals dynamic molecular and medical phenotypes R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ... Cell 148 (6), 1293-1307, 2012 | 1401 | 2012 |
| Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Tee, ... Clinical Pharmacology and Therapeutics 93 (4), 324-5, 2013 | 889 | 2013 |
| Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Tee, ... Clinical Pharmacology and Therapeutics 89 (2), 387-91, 2011 | 889 | 2011 |
| The BioPAX community standard for pathway data sharing E Demir, MP Cary, S Paley, K Fukuda, C Lemer, I Vastrik, G Wu, ... Nature biotechnology 28 (9), 935-942, 2010 | 807 | 2010 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ... Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011 | 776 | 2011 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ... Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017 | 645 | 2017 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update MV Relling, M Schwab, M Whirl‐Carrillo, G Suarez‐Kurtz, CH Pui, ... Clinical Pharmacology & Therapeutics 105 (5), 1095-1105, 2019 | 568 | 2019 |
| Clinical interpretation and implications of whole-genome sequencing FE Dewey, ME Grove, C Pan, BA Goldstein, JA Bernstein, H Chaib, ... Jama 311 (10), 1035-1045, 2014 | 529 | 2014 |
| Prediction of CYP2D6 phenotype from genotype across world populations A Gaedigk, K Sangkuhl, M Whirl-Carrillo, T Klein, JS Leeder Genetics in Medicine 19 (1), 69-76, 2017 | 510 | 2017 |
| Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ... Genetics in Medicine 19 (2), 215-223, 2017 | 503 | 2017 |
| An evidence‐based framework for evaluating pharmacogenomics knowledge for personalized medicine M Whirl‐Carrillo, R Huddart, L Gong, K Sangkuhl, CF Thorn, R Whaley, ... Clinical Pharmacology & Therapeutics 110 (3), 563-572, 2021 | 457 | 2021 |
| Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and … KE Caudle, K Sangkuhl, M Whirl‐Carrillo, JJ Swen, CE Haidar, TE Klein, ... Clinical and translational science 13 (1), 116-124, 2020 | 457 | 2020 |
| Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process KE Caudle, TE Klein, JM Hoffman, DJ Müller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209, 2014 | 457 | 2014 |
| The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database A Gaedigk, M Ingelman‐Sundberg, NA Miller, JS Leeder, M Whirl‐Carrillo, ... Clinical Pharmacology & Therapeutics 103 (3), 399-401, 2018 | 399 | 2018 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy MP Goetz, K Sangkuhl, HJ Guchelaar, M Schwab, M Province, ... Clinical Pharmacology & Therapeutics 103 (5), 770-777, 2018 | 323 | 2018 |
| Cytochrome P450 2C9-CYP2C9 D Van Booven, S Marsh, H McLeod, MW Carrillo, K Sangkuhl, TE Klein, ... Pharmacogenetics and genomics 20 (4), 277-281, 2010 | 309 | 2010 |
| PharmGKB: a worldwide resource for pharmacogenomic information JM Barbarino, M Whirl‐Carrillo, RB Altman, TE Klein Wiley Interdisciplinary Reviews: Systems Biology and Medicine 10 (4), e1417, 2018 | 284 | 2018 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing KE Caudle, AE Rettie, M Whirl‐Carrillo, LH Smith, S Mintzer, MTM Lee, ... Clinical Pharmacology & Therapeutics 96 (5), 542-548, 2014 | 274 | 2014 |
| The clinical pharmacogenetics implementation consortium: 10 years later MV Relling, TE Klein, RS Gammal, M Whirl‐Carrillo, JM Hoffman, ... Clinical Pharmacology & Therapeutics 107 (1), 171-175, 2020 | 271 | 2020 |
